Derrick P. McCarthy, Ph.D. - Publications

Affiliations: 
2013 Integrated Graduate Program in the Life Sciences Northwestern University, Evanston, IL 
Area:
Molecular Neuroscience, Neurobiology of Disease, Neuroimmunology

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 McCarthy DP, Yap JW, Harp CT, Song WK, Chen J, Pearson RM, Miller SD, Shea LD. An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 27720992 DOI: 10.1016/j.nano.2016.09.007  0.8
2015 Traka M, Podojil JR, McCarthy DP, Miller SD, Popko B. Oligodendrocyte death results in immune-mediated CNS demyelination. Nature Neuroscience. PMID 26656646 DOI: 10.1038/nn.4193  0.8
2015 Hlavaty KA, McCarthy DP, Saito E, Yap WT, Miller SD, Shea LD. Tolerance induction using nanoparticles bearing HY peptides in bone marrow transplantation. Biomaterials. 76: 1-10. PMID 26513216 DOI: 10.1016/j.biomaterials.2015.10.041  0.8
2015 McCarthy DP, Bryant J, Galvin JP, Miller SD, Luo X. Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cells. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 15: 1475-83. PMID 25807873 DOI: 10.1111/ajt.13237  0.8
2014 McCarthy DP, Hunter ZN, Chackerian B, Shea LD, Miller SD. Targeted immunomodulation using antigen-conjugated nanoparticles. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 6: 298-315. PMID 24616452 DOI: 10.1002/wnan.1263  0.8
2014 Hunter Z, McCarthy DP, Yap WT, Harp CT, Getts DR, Shea LD, Miller SD. A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease. Acs Nano. 8: 2148-60. PMID 24559284 DOI: 10.1021/nn405033r  0.8
2014 Getts DR, Terry RL, Getts MT, Deffrasnes C, Müller M, van Vreden C, Ashhurst TM, Chami B, McCarthy D, Wu H, Ma J, Martin A, Shae LD, Witting P, Kansas GS, et al. Therapeutic inflammatory monocyte modulation using immune-modifying microparticles. Science Translational Medicine. 6: 219ra7. PMID 24431111 DOI: 10.1126/scitranslmed.3007563  0.8
2013 Getts DR, McCarthy DP, Miller SD. Exploiting apoptosis for therapeutic tolerance induction. Journal of Immunology (Baltimore, Md. : 1950). 191: 5341-6. PMID 24244028 DOI: 10.4049/jimmunol.1302070  0.8
2012 Getts DR, Martin AJ, McCarthy DP, Terry RL, Hunter ZN, Yap WT, Getts MT, Pleiss M, Luo X, King NJ, Shea LD, Miller SD. Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. Nature Biotechnology. 30: 1217-24. PMID 23159881 DOI: 10.1038/nbt.2434  0.8
2012 McCarthy DP, Richards MH, Miller SD. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease. Methods in Molecular Biology (Clifton, N.J.). 900: 381-401. PMID 22933080 DOI: 10.1007/978-1-60761-720-4_19  0.8
2011 Getts DR, Turley DM, Smith CE, Harp CT, McCarthy D, Feeney EM, Getts MT, Martin AJ, Luo X, Terry RL, King NJ, Miller SD. Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells. Journal of Immunology (Baltimore, Md. : 1950). 187: 2405-17. PMID 21821796 DOI: 10.4049/jimmunol.1004175  0.8
2010 Getts DR, Getts MT, McCarthy DP, Chastain EM, Miller SD. Have we overestimated the benefit of human(ized) antibodies? Mabs. 2: 682-94. PMID 20935511 DOI: 10.4161/mabs.2.6.13601  0.8
2010 Martin AJ, McCarthy D, Waltenbaugh C, Goings G, Luo X, Miller SD. Ethylenecarbodiimide-treated splenocytes carrying male CD4 epitopes confer histocompatibility Y chromosome antigen transplant protection by inhibiting CD154 upregulation. Journal of Immunology (Baltimore, Md. : 1950). 185: 3326-36. PMID 20713889 DOI: 10.4049/jimmunol.1000802  0.8
2008 Luo X, Pothoven KL, McCarthy D, DeGutes M, Martin A, Getts DR, Xia G, He J, Zhang X, Kaufman DB, Miller SD. ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms. Proceedings of the National Academy of Sciences of the United States of America. 105: 14527-32. PMID 18796615 DOI: 10.1073/pnas.0805204105  0.8
Show low-probability matches.